[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100460984":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":13,"centralContacts":21,"locations":31,"responsibleParty":62,"collaborators":64,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":69,"sex":75,"minAge":76,"maxAge":10,"enrollmentInfo":77,"targetDuration":10,"studyType":80,"phases":10,"briefSummary":81,"conditions":82,"keywords":86,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Fresenius Medical Care Deutschland GmbH","INDUSTRY",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"aHD: Acute haemodialysis patients",null,{"label":12,"type":10,"description":10,"interventionNames":10},"cHD: Chronic haemodialysis patients",[14,18],{"name":15,"affiliation":16,"role":17},"Martin Brauer, Dr. med.","Jena University Hospital","PRINCIPAL_INVESTIGATOR",{"name":19,"affiliation":20,"role":17},"Bernhard Schmidt, Prof Dr med","Hannover Medical School",[22,27],{"name":23,"role":24,"phone":25,"phoneExt":10,"email":26},"Tatiana De los Rios","CONTACT","+49 6172 608 2362","Tatiana.De-Los-Rios@fmc-ag.com",{"name":28,"role":24,"phone":29,"phoneExt":10,"email":30},"Jana Schmitt","+49 6172 609 95403","Jana.Schmitt@fmc-ag.com",[32,49],{"facility":33,"status":34,"city":35,"state":10,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Medizinische Hochschule Hannover","RECRUITING","Hanover","30625","Germany","DE",{"type":40,"coordinates":41},"Point",[42,43],9.73322,52.37052,{"lat":43,"lon":42},[46],{"name":47,"role":24,"phone":10,"phoneExt":10,"email":48},"Bernhard Schmidt, Prof.Dr.","Schmidt.Bernhard@mh-hannover.de",{"facility":50,"status":34,"city":51,"state":10,"zip":52,"country":37,"countryCode":38,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Universitätsklinikum Jena","Jena","07743",{"type":40,"coordinates":54},[55,56],11.5899,50.92878,{"lat":56,"lon":55},[59],{"name":60,"role":24,"phone":10,"phoneExt":10,"email":61},"Brauer Martin, Dr.","martin.brauer@med.uni-jena.de",{"type":63,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[65],{"name":66,"class":6},"Alcedis GmbH","100460984","retrospective-analysis-of-performance-and-treatment-data-collected-for-genius-sleddflux-filter-ultraflux-av-600-s-filter--genius-90-concentrates-in-haemodialysis-patients-100460984",false,"NCT05282732","Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients","Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Acute Haemodialysis, Haemodynamically Instable Patients and Chronic Haemodialysis Patients","Genius","Inclusion Criteria:\n\n* All patients with an indication for the extracorporeal blood treatment suffering from renal insufficiency who received all treatments, between January 2019 and December 2019, with the investigational devices have to be included in the study in chronological order.\n* For aHD patients: availability of at least 3 of the 5 primary variables (daily urea, creatinine, potassium, ultrafiltration and effluent volume) for 50 % of the documented treatments.\n* For cHD patients: availability of the ultrafiltration values for all treatments and at least one value for urea and creatinine per week\n\nExclusion Criteria:\n\n* Simultaneous use of another filter\u002Fadsorber for another form of therapy","ALL","18 Years",{"count":78,"type":79},100,"ESTIMATED","OBSERVATIONAL","Retrospective analysis of performance and treatment data collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter \\& Genius 90 Concentrates in acute haemodialysis, haemodynamically instable patients and chronic haemodialysis patients\n\n* to analyse performance and treatment data from patients treated with the investigational device\n* to evaluate the filter characteristics for aHD (Acute haemodialysis) patients\n* to evaluate the improvement of kidney function for aHD patients",[83,84,85],"Renal Failure","End Stage Renal Disease","Acute Renal Failure",[87,88,89],"Hemodialysis","Genius system","Slow extended daily dialysis","2025-06-17",{"date":92,"type":93},"2025-06-22","ACTUAL",{"date":95,"type":93},"2022-10-07",{"date":97,"type":79},"2025-12",{"name":5,"class":6},2]